Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-17-044529
Filing Date
2017-07-11
Accepted
2017-07-11 17:37:17
Documents
1
Period of Report
2017-07-07

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 11012
  Complete submission text file 0001104659-17-044529.txt   13683
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 25 FIRST ST STE 303 CAMBRIDGE MA 02141
Business Address 25 FIRST ST STE 303 CAMBRIDGE MA 02141 6175882695
Atlas Venture Associates IX, LLC (Reporting) CIK: 0001671207 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1012
Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 17960619

Mailing Address 25 FIRST ST STE 303 CAMBRIDGE MA 02141
Business Address 25 FIRST ST STE 303 CAMBRIDGE MA 02141 6175882695
Atlas Venture Associates IX, L.P. (Reporting) CIK: 0001671208 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1012
Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 17960620

Mailing Address 25 FIRST ST STE 303 CAMBRIDGE MA 02141
Business Address 25 FIRST ST STE 303 CAMBRIDGE MA 02141 6175882695
Atlas Venture Fund IX, L.P. (Reporting) CIK: 0001671219 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1012
Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 17960621